Skip to content

Meet us at COP31Read more

Eli Lilly and Co Sustainability Reports

Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products worldwide. The company focuses on therapeutic areas including diabetes, obesity, oncology, immunology, and neuroscience.

Sector: Manufacturing

Country: United States

Exchange: New York Stock Exchange

LEI: FRDRIPF3EKNDJ2CQJL29

FIGI: BBG001S5STL8

42 reports from 1995 to 2025